EP3362070
COMBINATION OF A MUTANT ISOCITRATE DEHYDROGENASE 2 INHIBITOR WITH AZACITIDINE AND ITS USE FOR TREATING ACUTE MYELOGENOUS LEUKEMIA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.10.2016EP published:
27.1.2021EP application number:
16788866.8
EPO information:
European Patent Register
Max expiry date:
13.10.2036
Title:
COMBINATION OF A MUTANT ISOCITRATE DEHYDROGENASE 2 INHIBITOR WITH AZACITIDINE AND ITS USE FOR TREATING ACUTE MYELOGENOUS LEUKEMIA
Timeline
Today
14.10.2016EP application
27.1.2021EP Publication
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Name:
Agios Pharmaceuticals, Inc.Address:
88 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
CHOPRA, Vivek, Saroj, KumarAddress:
South San Francisco, CA 94080, US
Name:
DIMARTINO,JorgeAddress:
Belmont, CA 94002, US
Name:
KENVIN, Laurie, A.Address:
New Hope, PA 18938, US
Name:
KNIGHT, Robert, DouglasAddress:
Berkeley Heights, NJ 07922, US
Name:
MACBETH, KyleAddress:
San Francisco, CA 94103, US
Name:
VISWANADHAN, KrishnanAddress:
East Hanover, NJ 07936, US
Name:
XU, QiangAddress:
Basking Ridge, NJ 07920, US
Name:
AGRESTA, Samuel, V.Address:
Lexington, MA 02420, US
Priority
Number:
201562242218 PDate:
15.10.2015Country:
US
Classification
Categories:
A61K 31/53, A61K 31/7068, A61P 35/00, A61P 35/02, A61K 45/06, A61K 9/00